vals007 p Search Results


95
Cell Signaling Technology Inc vals007 p
Rare or novel heterozygous non-silent variants in the FIG4 gene predicted to be deleterious identified in 201 central European ALS patients
Vals007 P, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vals007 p/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
vals007 p - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Rare or novel heterozygous non-silent variants in the FIG4 gene predicted to be deleterious identified in 201 central European ALS patients

Journal: European Journal of Human Genetics

Article Title: FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study

doi: 10.1038/ejhg.2016.186

Figure Lengend Snippet: Rare or novel heterozygous non-silent variants in the FIG4 gene predicted to be deleterious identified in 201 central European ALS patients

Article Snippet: Varying degrees of brain atrophy, particularly in the frontoparietal region, were found in all FIG4 variant carriers by cranial MRI. table ft1 table-wrap mode="anchored" t5 caption a7 Patient Amino-acid change Inheri-tance Gender Country of origin Age of onset (years) Site of onset Diagnosis El Escorial Diseaseduration (years) a Neurological non-motor neuron symptoms EMG NCS Cranial MRI MD072 p.(I41T) Sporadic F Italy 43 Spinal PLS Possible ALS 12.25 Pathological laughing and crying No acute/chronic denervation Normal Precentral gyrus thinning, mild frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST FamALS006–01 p.(F254Sfs*8) Familial M Germany 40 Spinal ALS Clinically probable ALS 2.67 None Acute/chronic denervation UE, LE, thoracic Reduction of CMAP and prolongation of DML Severe frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST VALS042 p.(D307N) Sporadic M Germany 78 Bulbar ALS-UMN Clinically probable ALS 5.25 Sensory impairment for vibration, light touch Chronic denervation UE, LE Motor-sensory axonal neuropathy Age-related symmetric atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS007 p.(T540I) Sporadic F Germany 72 Bulbar PLS Possible ALS 3.25 Mild cognitive impairment, sensory impairment for vibration Sparse and stable signs of acute/chronic denervation (LE only) Reduction of CMAP and prolongation of DML Moderate frontoparietal atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS012 p.(Y647C) Sporadic M Germany 66 Spinal ALS-flail arm — 5.25 None Acute/chronic denervation UE, LE Motor-sensory axonal neuropathy Mild frontoparietal atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS015 p.(S853L) Sporadic F Germany 48 Spinal ALS Clinically probable ALS 0.92 Minimal sensory impairment for vibration Acute/chronic denervation Mild motor–sensory axonal neuropathy Mild frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST Open in a separate window Abbreviations: ALS, amyotrophic lateral sclerosis; CMAP, compound motor action potential; CST, corticospinal tract; DML, distal motor latency; EMG, electromyography; F, female; LE, lower extremity; M, male; MRI, magnetic resonance imaging; NCS, nerve conduction study; PLS, primary lateral sclerosis; UE, upper extremity; UMN, upper motor neuron.

Techniques:

Clinical, electrophysiological, and neuroradiological characteristics of ALS patients carrying heterozygous deleterious FIG4 variants

Journal: European Journal of Human Genetics

Article Title: FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study

doi: 10.1038/ejhg.2016.186

Figure Lengend Snippet: Clinical, electrophysiological, and neuroradiological characteristics of ALS patients carrying heterozygous deleterious FIG4 variants

Article Snippet: Varying degrees of brain atrophy, particularly in the frontoparietal region, were found in all FIG4 variant carriers by cranial MRI. table ft1 table-wrap mode="anchored" t5 caption a7 Patient Amino-acid change Inheri-tance Gender Country of origin Age of onset (years) Site of onset Diagnosis El Escorial Diseaseduration (years) a Neurological non-motor neuron symptoms EMG NCS Cranial MRI MD072 p.(I41T) Sporadic F Italy 43 Spinal PLS Possible ALS 12.25 Pathological laughing and crying No acute/chronic denervation Normal Precentral gyrus thinning, mild frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST FamALS006–01 p.(F254Sfs*8) Familial M Germany 40 Spinal ALS Clinically probable ALS 2.67 None Acute/chronic denervation UE, LE, thoracic Reduction of CMAP and prolongation of DML Severe frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST VALS042 p.(D307N) Sporadic M Germany 78 Bulbar ALS-UMN Clinically probable ALS 5.25 Sensory impairment for vibration, light touch Chronic denervation UE, LE Motor-sensory axonal neuropathy Age-related symmetric atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS007 p.(T540I) Sporadic F Germany 72 Bulbar PLS Possible ALS 3.25 Mild cognitive impairment, sensory impairment for vibration Sparse and stable signs of acute/chronic denervation (LE only) Reduction of CMAP and prolongation of DML Moderate frontoparietal atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS012 p.(Y647C) Sporadic M Germany 66 Spinal ALS-flail arm — 5.25 None Acute/chronic denervation UE, LE Motor-sensory axonal neuropathy Mild frontoparietal atrophy and ventricular enlargement, no T2 hyperintensity in the CST VALS015 p.(S853L) Sporadic F Germany 48 Spinal ALS Clinically probable ALS 0.92 Minimal sensory impairment for vibration Acute/chronic denervation Mild motor–sensory axonal neuropathy Mild frontoparietal atrophy, no ventricular enlargement, no T2 hyperintensity in the CST Open in a separate window Abbreviations: ALS, amyotrophic lateral sclerosis; CMAP, compound motor action potential; CST, corticospinal tract; DML, distal motor latency; EMG, electromyography; F, female; LE, lower extremity; M, male; MRI, magnetic resonance imaging; NCS, nerve conduction study; PLS, primary lateral sclerosis; UE, upper extremity; UMN, upper motor neuron.

Techniques: